Delivery Order SPE2DB20D2104-SPE2DB24FT91U

Award Date 4/29/24
Potential Completion Date 4/30/24
Potential Value $1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of DICLOFENAC SOD ER 100 MG TAB 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 30, 2024 with a ceiling value of $1,454.21. The contract is a Firm Fixed Price Delivery Order with a completion date of December 31, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug...
This federal contract award is for the delivery of Diclofenac Sodium Extended-Release 100 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,903.71 and a completion date of June 21, 2023. The award was made on June 20, 2023, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a subsidiary...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DICLOFENAC POT 50 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price of $3,543.11 and a completion date of May 27, 2025. This appears to be a delivery order contract, not associated with a larger contract vehicle. The contract is not set aside for any specific...
The federal contract award SPE2DB22D2007|SPE2DB24FH7NS was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,451.32 delivery order contract is for the supply of 4562966710 DICLOFENAC POT 50 MG TABLET 100S. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,069.02, is for the delivery of DICLOFENAC SODIUM 1% GEL 50GM, with an ultimate completion date of October 31, 2024. This contract is a Delivery Order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 IDC running through...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, valued at $57,324.19, is for the supply of Diclofenac Potassium 50 mg powder packets. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and medical supplies to support DLA programs. This delivery order is not associated with a set-aside designation....
This federal contract award, valued at $1,493.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4,568,201,898 units of Diclofenac Sodium Delayed-Release 75 mg tablets. The contract has a firm fixed price and an ultimate completion date of May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $2,691.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4556999666 DICLOFENAC-MISOPROST 75-0.2 MG 60S, a pharmaceutical product, with a completion date of April 26, 2022. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary...
This federal contract award, valued at $1,431.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of diclofenac sodium 1% gel, a topical anti-inflammatory medication, with a completion date of February 26, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, SPE2DB20D1004|SPE2DB25FNGQJ, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568037981 - DICLOFENAC-MISOPROST 50-0.2 MG 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,109.05 and an ultimate completion date of April 28, 2025. The contract is not set aside and was open...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FT91U
    Delivery Order

This federal contract award is for the delivery of diclofenac potassium 50 mg tablets (100 count) to the Defense Logistics Agency (DLA). The contract, valued at $1,016.48, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award has an ultimate completion date of April 30, 2024. This contract is a delivery order and is priced on a firm fixed-price basis. The contract does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the DLA and Department of Justice. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000, respectively, for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs.

Generated 2/27/25, 12:12 PM